Solid state transformations in consequence of electrospraying--a novel polymorphic form of piroxicam.
暂无分享,去创建一个
Matti Murtomaa | Jarno Salonen | Hélder A Santos | Jorma Roine | H. Santos | Jorma Roine | M. Nyström | M. Murtomaa | J. Salonen | Maija Nyström | R Mohan Sankaran | R. Mohan Sankaran
[1] Bernhardt L Trout,et al. Production and characterization of carbamazepine nanocrystals by electrospraying for continuous pharmaceutical manufacturing. , 2011, Journal of pharmaceutical sciences.
[2] M. Sarkar,et al. Spectroscopic studies of microenvironment dictated structural forms of piroxicam and meloxicam , 2002 .
[3] A. Bailey,et al. ELECTROSTATIC SPRAYING OF LIQUIDS , 1988 .
[4] R. N. Brogden,et al. Piroxicam: A Review of its Pharmacological Properties and Therapeutic Efficacy , 1981, Drugs.
[5] J. Rantanen,et al. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling. , 2012, International journal of pharmaceutics.
[6] Michael J Cima,et al. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.
[7] A. Whittington,et al. Melting point depression of Piroxicam in carbon dioxide + co-solvent mixtures and inclusion complex formation with β-cyclodextrin , 2012 .
[8] S. M. Andrade,et al. Hydrogen bonding effects in the photophysics of a drug, Piroxicam, in homogeneous media and dioxane–water mixtures , 1999 .
[9] F. Vrečer,et al. Characterization of piroxicam crystal modifications. , 2003, International journal of pharmaceutics.
[10] A. Nokhodchi,et al. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling. , 2013, Colloids and surfaces. B, Biointerfaces.
[11] Complementing high-throughput X-ray powder diffraction data with quantum-chemical calculations: Application to piroxicam form III. , 2012, Journal of pharmaceutical sciences.
[12] A. D'Ursi,et al. Piroxicam loaded alginate beads obtained by prilling/microwave tandem technique: morphology and drug release. , 2012, Carbohydrate polymers.
[13] M. Janik,et al. Influence of solvent effect on polymorphism of 4-hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide-1, 1-dioxide (piroxicam) , 1991 .
[14] John A. Lowe,et al. A guide to drug discovery: The role of the medicinal chemist in drug discovery — then and now , 2004, Nature Reviews Drug Discovery.
[15] P. Taddei,et al. Influence of environment on piroxicam polymorphism: vibrational spectroscopic study. , 2001, Biopolymers.
[16] Kenneth I. Hardcastle,et al. Cocrystals of Piroxicam with Carboxylic Acids , 2007 .
[17] M. Nyström,et al. Fabrication and characterization of drug particles produced by electrospraying into reduced pressure , 2010 .
[18] N. Sandler,et al. Processing of pharmaceutical materials by electrospraying under reduced pressure , 2015, Drug development and industrial pharmacy.
[19] Chick C. Wilson,et al. Tautomerisation and polymorphism in molecular complexes of piroxicam with mono-substituted benzoic acids , 2012 .
[20] E. Höhne,et al. X-ray studies on piroxicam modifications. , 1988, Die Pharmazie.
[21] J. Bordner,et al. Deuterium isotope effects on carbon-13 NMR shifts and the tautomeric equilibrium in N-substituted pyridyl derivatives of piroxicam , 1989 .
[22] G. Reck,et al. Prediction and establishment of a new crystalline piroxicam modification. , 1990, Die Pharmazie.
[23] R. Pansu,et al. The Influence of Water on the Photophysical and Photochemical Properties of Piroxicam in AOT/iso‐octane/Water Reversed Micelles , 2000, Photochemistry and photobiology.
[24] J. Heinämäki,et al. Water-mediated solid-state transformation of a polymorphic drug during aqueous-based drug-layer coating of pellets. , 2013, International journal of pharmaceutics.
[25] Anatol Jaworek,et al. Micro- and nanoparticle production by electrospraying , 2007 .
[26] A. T. Sobczyk,et al. Electrospraying route to nanotechnology: An overview , 2008 .
[27] B. Kojić-Prodić,et al. Structure of the anti‐inflammatory drug 4‐hydroxy‐2‐methyl‐N‐2‐pyridyl‐2H‐1λ6,2‐benzothiazine‐3‐carboxamide 1,1‐dioxide (piroxicam) , 1982 .
[28] J. Lubach,et al. Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes. , 2005, Journal of the American Chemical Society.
[29] P. Taddei,et al. Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound. , 1999, Biospectroscopy.
[30] G. Reck,et al. Prediction and establihement of a new crystalline pyroxicam modification , 1990 .
[31] J. Richards,et al. Piroxicam monohydrate: a zwitterionic form, C15H13N3O4S.H2O , 1984 .
[32] J. M. Grace,et al. A review of liquid atomization by electrical means , 1994 .
[33] I. Kikic,et al. Piroxicam solid state studies after processing with SAS technique , 2010 .
[34] H. Chakraborty,et al. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam. , 2003, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[35] E. Whipple,et al. Zwitterionic piroxicam in polar solution , 1989 .
[36] G. Angioni,et al. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[37] S. Bates,et al. Polymorphism in Piroxicam , 2004 .
[38] M. Nyström,et al. Fabrication of amorphous pharmaceutical materials by electrospraying into reduced pressure , 2011 .
[39] Hyunbong Choi,et al. Solvent Dependence of Absorption and Fluorescence Spectra of Piroxicam. A Possible Intramolecular Proton Transfer in the Excited State , 1989 .